Unichem sells Indore SEZ plant to Mylan for $26.3M

3 years ago

Unichem Laboratories Ltd is selling its Indore-based SEZ plant to generic and specialty pharmaceuticals maker Mylan Laboratories Ltd for Rs 161 crore ($26.27 million), as per a stock market disclosure.

“The board of directors of Unichem at its meeting held on February 15, 2013 had approved the sale of Indore SEZ plant to Mylan and members of the company had approved the sale on March 29, 2013 through a postal ballot,” the company said in the filing.

Mumbai-headquartered Unichem makes pharmaceutical ingredients and pharmaceutical formulations for various therapeutic areas, including gastro-intestinal, cardiovascular, diabetes, psychiatry, neurology, anti-bacterial, anti-infectives and pain management. It has six drug manufacturing locations across the country. 

Founded in 2001, Hyderabad-based Mylan works as a subsidiary of US-based Mylan Inc. The company manufactures and supplies active pharmaceutical ingredients. 

Last October, Mylan acquired a Visakhapatnam-based unit from SMS Pharmaceuticals Ltd for $33 million.

This August, Mylan Inc received approval of Foreign Investment Promotion Board, the nodal government body monitoring foreign investment in the country, for its Rs 5,168 crore foreign direct investment (FDI) proposal to finance the acquisition of Agila Specialties Pvt Ltd.

(Edited by Joby Puthuparampil Johnson)


View Comments
SMS Pharmaceuticals sells Visakhapatnam unit to Mylan for $33M

SMS Pharmaceuticals sells Visakhapatnam unit to Mylan for $33M

TEAM VCC 4 years ago
SMS Pharmaceuticals has sold its manufacturing units in Visakhapatnam to generic and specialty pharmaceuticals maker Mylan Laboratories for Rs 173 crore ($33 million), said the...
Is M&A activity replacing R&D in pharma sector?

Is M&A activity replacing R&D in pharma sector?

Ankit Mishra and Simone Reis and Tanya Pahwa 2 years ago
Mylan Emerges Victorious! Of Strategies, Lifesavers and Poison Pills The heightened M&A deal activity in the pharmaceutical sector globally has the industry in frenzy. A...
Mylan to buy Strides Arcolab’s injectables unit Agila for $1.6B

Mylan to buy Strides Arcolab’s injectables unit Agila for $1.6B

TEAM VCC 4 years ago
Mylan Inc has struck a deal to acquire Agila Specialties Pvt Ltd, a developer, manufacturer and marketer of generic injectable products, from Strides Arcolab Ltd...
No Comments

Unichem sells Indore SEZ plant to Mylan for $26.3M

Powered by WordPress.com VIP